» Articles » PMID: 23526980

White Blood Cell Counts As Risk Markers of Developing Metabolic Syndrome and Its Components in the PREDIMED Study

Abstract

Background: The Metabolic Syndrome (MetS) is a cluster of metabolic abnormalities that includes hyperglucemia, hypertension, dyslipidemia and central obesity, conferring an increased risk of cardiovascular disease. The white blood cell (WBC) count has been proposed as a marker for predicting cardiovascular risk. However, few prospective studies have evaluated the relationship between WBC subtypes and risk of MetS.

Methods: Participants were recruited from seven PREDIMED study centers. Both a baseline cross-sectional (n = 4,377) and a prospective assessment (n = 1,637) were performed. Participants with MetS at baseline were excluded from the longitudinal analysis. The median follow-up was 3.9 years. Anthropometric measurements, blood pressure, fasting glucose, lipid profile and WBC counts were assessed at baseline and yearly during the follow-up. Participants were categorized by baseline WBC and its subtype count quartiles. Adjusted logistic regression models were fitted to assess the risk of MetS and its components.

Results: Of the 4,377 participants, 62.6% had MetS at baseline. Compared to the participants in the lowest baseline sex-adjusted quartile of WBC counts, those in the upper quartile showed an increased risk of having MetS (OR, 2.47; 95%CI, 2.03-2.99; P-trend<0.001). This association was also observed for all WBC subtypes, except for basophils. Compared to participants in the lowest quartile, those in the top quartile of leukocyte, neutrophil and lymphocyte count had an increased risk of MetS incidence. Leukocyte and neutrophil count were found to be strongly associated with the MetS components hypertriglyceridemia and low HDL-cholesterol. Likewise, lymphocyte counts were found to be associated with the incidence of the MetS components low HDL-cholesterol and high fasting glucose. An increase in the total WBC during the follow-up was also associated with an increased risk of MetS.

Conclusions: Total WBC counts, and some subtypes, were positively associated with MetS as well as hypertriglyceridemia, low HDL-cholesterol and high fasting glucose, all components of MetS.

Trial Registration: Controlled-Trials.comISRCTN35739639.

Citing Articles

The association between white blood cell counts and metabolic health obesity among US adults.

Li Z, Yao Z, Liu Q Front Nutr. 2025; 12:1458764.

PMID: 39895838 PMC: 11784339. DOI: 10.3389/fnut.2025.1458764.


Association Between Triglyceride-Glucose Index and Lung Function Parameters in the General Population Undergoing Health Examinations.

Yang Y, Wang S, Jia B, Chen S Diabetes Metab Syndr Obes. 2024; 17:4031-4047.

PMID: 39492961 PMC: 11531295. DOI: 10.2147/DMSO.S487744.


Eosinophil biology from the standpoint of metabolism: implications for metabolic disorders and asthma.

Haruna N, Berdnikovs S, Nie Z J Leukoc Biol. 2024; 116(2):288-296.

PMID: 38700084 PMC: 11288379. DOI: 10.1093/jleuko/qiae100.


Eosinophils in obesity and obesity-associated disorders.

Hu Y, Chakarov S Discov Immunol. 2024; 2(1):kyad022.

PMID: 38567054 PMC: 10917198. DOI: 10.1093/discim/kyad022.


Metabolic syndrome in adults with autistic traits: associated psychological, behavioral, and biological factors in females and males - a PharmLines initiative.

Warreman E, Nooteboom L, Leenen P, Geurts H, Terry M, Bos J Front Psychiatry. 2024; 14:1303840.

PMID: 38193131 PMC: 10773724. DOI: 10.3389/fpsyt.2023.1303840.


References
1.
Estruch R, Martinez-Gonzalez M, Corella D, Salas-Salvado J, Ruiz-Gutierrez V, Covas M . Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med. 2006; 145(1):1-11. DOI: 10.7326/0003-4819-145-1-200607040-00004. View

2.
Nagasawa N, Tamakoshi K, Yatsuya H, Hori Y, Ishikawa M, Murata C . Association of white blood cell count and clustered components of metabolic syndrome in Japanese men. Circ J. 2004; 68(10):892-7. DOI: 10.1253/circj.68.892. View

3.
Danesh J, Collins R, Appleby P, Peto R . Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA. 1998; 279(18):1477-82. DOI: 10.1001/jama.279.18.1477. View

4.
Imano H, Sato S, Kitamura A, Kiyama M, Ohira T, Shimamoto T . Leukocyte count is an independent predictor for risk of acute myocardial infarction in middle-aged Japanese men. Atherosclerosis. 2006; 195(1):147-52. DOI: 10.1016/j.atherosclerosis.2006.09.002. View

5.
Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M . Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001; 24(4):683-9. DOI: 10.2337/diacare.24.4.683. View